71 related articles for article (PubMed ID: 9351465)
21. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
[TBL] [Abstract][Full Text] [Related]
22. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?].
Os I; Stenehjem A; Høieggen A; Draganov B; Jenssen T; Holdaas H
Tidsskr Nor Laegeforen; 2002 Apr; 122(9):918-20. PubMed ID: 12082835
[TBL] [Abstract][Full Text] [Related]
23. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
Aksnes TA; Flaa A; Strand A; Kjeldsen SE
J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
[TBL] [Abstract][Full Text] [Related]
24. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
Davie AP; Rumley A; Lowe GD; McMurray JJ
Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
[No Abstract] [Full Text] [Related]
25. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
26. [New therapeutic perspectives associated with the introduction of angiotensin II receptor antagonists].
Peczkowska M; Kabat M; Janaszek-Sitkowska H
Pol Arch Med Wewn; 1997 Apr; 97(4):379-90. PubMed ID: 9411416
[No Abstract] [Full Text] [Related]
27. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
28. [Angiotensin II receptor antagonists. Clinically significant differences].
Ibsen H; Rasmussen S
Ugeskr Laeger; 1999 Sep; 161(38):5332-6. PubMed ID: 10536525
[No Abstract] [Full Text] [Related]
29. Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.
Winkelmayer WC; Zhang Z; Shahinfar S; Cooper ME; Avorn J; Brenner BM
Diabetes Care; 2006 Oct; 29(10):2210-7. PubMed ID: 17003295
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective].
de Boer RA; van Veldhuisen DJ; Gans RO; Gansevoort RT
Ned Tijdschr Geneeskd; 2003 Jan; 147(3):96-9. PubMed ID: 12577767
[TBL] [Abstract][Full Text] [Related]
31. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
[TBL] [Abstract][Full Text] [Related]
32. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
[TBL] [Abstract][Full Text] [Related]
33. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
34. [Respiratory and renal functions and blood electrolytic composition in patients with pulmonary tuberculosis in the treatment of heart failure].
Ditiatkov AE; Radzevich AE; Tikhonov VA; Zholnin PA; Mal'gina GV
Probl Tuberk; 2002; (4):39-41. PubMed ID: 12125252
[TBL] [Abstract][Full Text] [Related]
35. Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts.
Maharsy WM; Kadi LN; Issa NG; Bitar KM; Der-Boghossian AH; Abrahamian R; Bikhazi AB
J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):59-65. PubMed ID: 17703431
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotective effect of angiotensin II receptor antagonists.
White M
Can J Cardiol; 1999 Nov; 15 Suppl F():10F-4F. PubMed ID: 10579747
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin blockade for hypertension: a promise fulfilled.
Brunner HR; Gavras H
Lancet; 2002 Mar; 359(9311):990-2. PubMed ID: 11937175
[No Abstract] [Full Text] [Related]
38. [Adrenalin and noradrenalin in the serum after administration of Verapamil for cardiac insufficiency].
Brisse B; Bender F
Med Welt; 1971 Feb; 6():207-9. PubMed ID: 5555034
[No Abstract] [Full Text] [Related]
39. Chronic beneficial effects of type 1 angiotensin II receptor antagonist in patients with chronic hypoxemic pulmonary diseases.
Ogawa M; Hirose N; Ogimoto M; Matsuki H; Miki K; Kinoshita M; Koga A; Saku K
Cardiology; 2002; 97(2):111-2. PubMed ID: 11978959
[No Abstract] [Full Text] [Related]
40. Losartan-associated atypical cutaneous lymphoid hyperplasia.
Viraben R; Lamant L; Brousset P
Lancet; 1997 Nov; 350(9088):1366. PubMed ID: 9365456
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
